Description

Drostanate 200 mg by Novotex Pharma contains Drostanolone Enanthate, a long-acting injectable anabolic-androgenic compound originally developed for medical use in the treatment of breast cancer and other hormone-sensitive conditions. In research, Drostanolone Enanthate is studied for its potential to improve nitrogen balance, support lean tissue maintenance, and provide anti-estrogenic effects without aromatization.

Each set of 10 × 1 mL ampoules is manufactured under stringent pharmaceutical standards, ensuring consistent purity, concentration, and sterility — strictly for laboratory and research use.

Product Details

• Active Ingredient: Drostanolone Enanthate

• Concentration: 200 mg per mL

• Form: Injectable solution (intramuscular)

• Package Size: 10 ampoules × 1 mL each

Pharmacokinetics
Drostanolone Enanthate has a half-life of approximately 5–7 days, allowing for less frequent injections compared to its propionate counterpart. It does not convert to estrogen, making it valuable in studies on tissue preservation without water retention or estrogenic side effects.

Usage Recommendations

• Typical Research Dosage (historic/experimental): 200–400 mg per week under research protocols.

• Current Use: For laboratory and research purposes only.

• Administration: Intramuscular injection

Disclaimer
This product is intended exclusively for laboratory and research use. It is not approved for human use or therapeutic application. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with pre-existing medical conditions. Researchers must follow all local regulations and laboratory best practices.